Ser92

Site Information
sDSRRPVsRGsGVNA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 451106

In vivo Characterization
Methods used to characterize site in vivo:	[32P] bio-synthetic labeling ( 2 ) , mass spectrometry ( 1 ) , peptide sequencing ( 2 )
Disease tissue studied:	breast cancer ( 1 )
Relevant cell line - cell type - tissue:	breast ( 1 ) , keratinocyte ( 2 ) , SIK (keratinocyte) ( 2 )

Upstream Regulation
Treatments:	phorbol_ester ( 2 )

References
1	Gu T (2008) CST Curation Set: 3732; Year: 2008; Biosample/Treatment: tissue, breast/untreated; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
2	Rice RH, et al. (1996) Identification of phosphorylation sites in keratinocyte transglutaminase. Biochem J 320 ( Pt 2), 547-50 8973564 Curated Info

References

Gu T (2008) CST Curation Set: 3732; Year: 2008; Biosample/Treatment: tissue, breast/untreated; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

Rice RH, et al. (1996) Identification of phosphorylation sites in keratinocyte transglutaminase. Biochem J 320 ( Pt 2), 547-50
8973564 Curated Info